CDMO Report: A Vital Link in Outsourced Pharma Services 

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Managing Director

Profile

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0006 SDoering casual

Director

Harris-Williams Bio-Crop 0003 AndreyDvorkin

HCLS Report CDMO LI web-media

Across the contract development and manufacturing organization ecosystem, several long-term growth drivers underpin a diverse set of M&A opportunities.

CDMO Report: M&A Opportunity in Outsourced Pharma Services

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 

Outsourced Pharma Services & Pharma Tech Q4 2024

Outsourced Pharma Commercialization: Growth in a Dynamic Time

Outsourced Pharma Services: New Data Shows Resurgence Is Underway

Return on Innovation: An Eight-Part Series

Related Insights

Outsourced Pharma Services & Pharma Tech Q4 2024

Outsourced Pharma Commercialization: Growth in a Dynamic Time

Outsourced Pharma Services: New Data Shows Resurgence Is Underway

Return on Innovation: An Eight-Part Series